Stock Events

Regeneron Pharmaceuticals (REGN) Q1 2024 Earnings

2FebConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
9.61
10.36
11.11
11.86

Details

Expected EPS
10.77
Actual EPS
11.86
Surprise EPS
1.09
Surprise Percent
+10.12%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 11.86 per share for Q1 2024.

0 Comments

Share your thoughts